Is bisphosphonate therapy for benign bone disease associated with impaired dental healing? A case-controlled study
<p>Abstract</p> <p>Background</p> <p>Bisphosphonates are common first line medications used for the management of benign bone disease. One of the most devastating complications associated with bisphosphonate use is osteonecrosis of the jaws which may be related to durat...
Main Authors: | Thomson Wendy, McCullough Michael, Clement John G, Brand Caroline, Borromeo Gelsomina L, Flitzanis Elly, Wark John D |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-04-01
|
Series: | BMC Musculoskeletal Disorders |
Online Access: | http://www.biomedcentral.com/1471-2474/12/71 |
Similar Items
-
Bisphosphonate Treatment of Benign Multifocal and Unifocal Osteolytic Tumours of Bone
by: C. L. M. H. Gibbons, et al.
Published: (2003-01-01) -
The effects of bisphosphonate on direct fracture healing
by: Savaridas, Terence
Published: (2011) -
Bisphosphonates and direct fracture healing: Area to be explored
by: Tarun Goyal, et al.
Published: (2014-01-01) -
Thalassaemia: the dental implications of bisphosphonate therapy
by: Navdeep Kumar
Published: (2014-12-01) -
BISPHOSPHONATE-RELATED OSTEONECROSIS OF THE JAW AND DENTAL IMPLANTS
by: Ala Hassan A. Qamheya, et al.
Published: (2016-01-01)